We looked at the way that the state was supporting coverage for GLP-1 medicines and found that this was a fairly significant cost driver, Gov
For more background on GLP-1 science and medical context, read a clinical overview of semaglutide here: Real-world effectiveness: what reviews and studies say Evidence base for injectable semaglutide and tirzepatide is robust, showing substantial weight loss in trials and real-world use
Limitations of Weight Loss Medications: Modest weight loss: Compared to bariatric surgery, weight loss with medications tends to be more modest, typically in the range of 5-15% of body weight
Positive results from its Type 2 diabetes trial have already been announced
A small percentage of patients may find that Semaglutide produces only a mild reduction in appetite, even after reaching the highest therapeutic doses
The telehealth partner uses your content during onboarding and follow ups